The ability of intraventricular infusion of apolipo protein E (apoE) to reduce neuronal damage after global cere bral ischemia was investigated in apoE-deficient and wild-type mice. ApoE (5 f-Lg/mL lipid-conjugated derived from human plasma; I f-LLIh, continuous infusion) significantly reduced neu ronal damage in the caudate nucleus and CA2 pyramidal cell layer by approximately 50% in apoE-deficient mice after global ischemia compared to vehicle infusion. In wild-type mice in-
The apolipoprotein E gene (A POE, gene; apoE, pro tein) exists as three different alleles in humans (E2, E3 and E4). APOE genotype underlies a genetically deter mined susceptibility to the effects of several forms of acute brain damage including that caused by head injury (Nicoll et aI., 1995; Teasdale et aI., 1997) , spontaneous intracerebral hemorrhage (Alberts et aI., 1995) , and re petitive traumatic brain injury in boxers (Jordan et aI., 1997) . The APOE E4 allele, carried by one third of the population, is associated with a worsened response or poorer outcome following the initial injury. ApoE is the most abundant apolipoprotein in cerebrospinal fluid (Pitas et aI., 1987) and is produced within the eNS (Linton et aI., 1991) primarily by astrocytes. After brain injury, apoE is markedly upregulated in astrocytes and fused with apoE, there was a trend for ischemic neuronal dam age to be reduced. ApoE-infused mice had a marked reduction in 4-hydroxynonenaI immunoreactivity, as a marker of lipid peroxidation. The results show that the presence of apoE at or after the time of injury can be neuroprotective, possibly via an anti-oxidant mechanism. Key Words: Apolipoprotein E-Global cerebral ischemia-Oxidative damage-Mouse.
accumulates in neurons within hours of the insult (Hors burgh et a!., 1996; Horsburgh et aI., 1999a ) and is con sistent with a role for apoE in synaptic remodelling, re pair, and regeneration (Poirier, 1994) . When the function of apoE is deficient or impaired, in genetically-modified apoE mice, there is an increased susceptibility of the brain to the effects of ischemic insults (Laskowitz et aI., 1997 b; Horsburgh et aI., 1999b) and closed head injury (Lomnitski et aI., 1997) . We have previously shown that apoE-deficient mice have approximately a twofold in crease in ischemic neuronal damage following a transient episode of global cerebral ischemia (Horsburgh et aI., 1999b) . We hypothesized that increasing the levels of apoE in the CSF is a possible mechanism by which to ameliorate neuronal damage associated with acute brain injury. The study determined the ability of intraventricu lar infusion of lipid-conjugated apoE to reduce neuronal damage after an episode of global ischemia in apoE deficient and wild-type mice. It has been proposed that apoE can modulate oxidative damage (Miyata and Smith, 1996) . The extent of 4-hydroxynonenal (4-HNE) (Ester bauer et aI., 1991) immunoreactivity, a marker of lipid peroxidation, was additionally examined in apoE-deficient and wild-type mice infused with Iipid conjugated apoE compared to vehicle-infused mice.
MATERIALS AND METHODS
ApoE-deficient mice were derived at Glaxo-Wellcome from a colony produced by Dr. Maeda and colleagues (University of North Carolina, U.S.A.) as previously de scribed (Horsburgh et ai., 1999b) . Briefly, homologous recombination in mouse embryonic stem cells (129J) was used to produce targeted knockout mutations of the apoE locus. Offspring were backcrossed with C57BLl6J mice (six times at Dr. Maeda's laboratory followed by further backcrossing at Glaxo-Wellcome). ApoE deficient (n = 24) and wild-type (n = 24) mice used in this study (12 to 16 week old males) were littermates which were produced by selective matings between het erozygous apoE knockout breeding pairs. The genotype of the mice was confirmed by polymerase chain reaction analysis.
Alzet osmotic minipumps (model 10030, delivery rate 1 f.1L1h) attached to a brain infusion cannula via a cath eter were filled with 100 f.1L of artificial CSF (mmol/L: Na, 150; K, 3; Ca, 1.4; Mg, 0.8; P, I; Cl, 155) or 100 f.1L of apoE (5 f.1g/mL in artificial CSF; derived from pooled human plasma, very-low density lipoprotein, Calbio chern, Novabiochem, U.K.). Each pump system was placed in a sealed container with sterile saline and kept at 37°C overnight to reach a steady state before implanting. Anesthesia was induced with 3% halothane in 70% N20 I 30% O2 and maintained at 2.5% for the duration of the experiment. The mice were put on a stereotactic frame and mechanically ventilated. Body temperature was strictly controlled at 37°C. A midline sagittal incision was made to expose the skull. Under sterile conditions an osmotic minipump was placed in a subcutaneous pouch under the skin of the neck and connected via a plastic catheter to the brain infusion cannula. A burr hole was drilled in the skull and the cannula placed into the right lateral ventricle at stereotactic coordinates (0.8 mm lat eral, 0.2 mm from Bregma, 2.5 mm below dura). The cannula was held in place with cyanacrylate glue and secured to the skull with dental cement and the skin was sutured. The mouse was then disconnected from the frame and allowed to breath spontaneously. Halothane was delivered via a face mask and the concentration reduced to 1.5%. Thirty minutes after the implantation of the intraventricular cannula, transient global cerebral ischemia was induced as previously described (Hors burgh et ai., 1999b) . Both common carotid arteries were occluded for exactly 17 minutes. The animals were placed in an incubator for 2 hours after which they were returned to the animal housing and allowed to recover. Animals were killed 72 hours after carotid artery occlu sion by perfusion fixation using 4% paraformaldehyde.
The brains were removed and post-fixed in 4% para formaldehyde for 2 hours and embedded in paraffin. Sec tions (6 f.1m) were cut and stained with hematoxylin and eosin. Adjacent sections were immunostained with anti-4-hydroxynonenal Michael adducts (4-HNE) (1 :2000, rabbit polyclonal, Calbiochem, Novabiochem). Sections were deparaffinized, rehydrated into citrate buffer (pH 6.0), incubated in a microwave oven twice for 5 minutes for antigen enhancement and for 30 minutes in hydrogen peroxide (3%). Nonspecific sites were blocked with 0.5% bovine serum albumin and 10% normal goat serum (I hour). After overnight incubation with anti-4HNE in blocker, the sections were incubated with biotinylated anti-rabbit IgG and processed with a Vectastain Elite kit (Vector Labs, U.K.). Color was developed using diami nobenzidine. Using a similar method, sections from apoE-deficient mice were immunostained with an anti body to apoE (I :5000; goat polyclonal, Chemicon Inter national Ltd., U.K.).
The numbers of morphologically normal neurons and neurons showing the features of ischemic cell change in the hematoxylin and eosin stained sections (Horsburgh et aI., 1999b) were counted in 3 different fields in both hemispheres of the caudate nucleus and CA2 pyramidal cell layer using a 10 mm 2 grid and x400 magnification.
The percentage of ischemic neurons in apoE-infused compared to vehicle-infused in apoE-deficient mice and in wild-type mice were compared using one-tailed Stu dent's unpaired t-test. Semi-quantitative assessment of cellular 4-HNE immunoreactivity was performed at x400 magnification. 4-Hydroxynonenal immunoreactiv ity was classified as follows: 0 = no cellular staining; I = <35% cellular staining; 2 = 35% to 70% cellular staining; 3 = >70% cellular staining. The extent of 4-HNE immunoreactivity in apoE-infused compared to vehicle-infused in apoE-deficient mice and in wild-type mice were compared using Student's unpaired (-test.
RESULTS
We chose to infuse a lipid-associated form of apoE (5 f.1g/mL), derived from pooled human plasma of all apoE isoforms and complexed with very low density lipopro tein and injected into the CSF ensuring direct delivery of apoE to the injured brain. ApoE in the CSF (and also within the extracellular space) is normally complexed to lipid which is required for apoE to be biologically active (Pitas et aI., 1987) . Furthermore, the infusion of apoE was initiated before the insult and continuously thereaf ter to ensure that apoE would be available immediately before and after ischemic injury. We sought to determine that exogenously administered apoE was present in brain parenchyma by immunostaining sections of apoE deficient mice with an antibody to apoE. We did find evidence that apoE immunostaining was increased in apoE-infused compared to vehicle-infused mice in brain parenchyma at the site of infusion but did not find evi dence that apoE immunostaining was increased distal from this (data not shown). Histological sections were examined from all animals to ensure that the cannula delivering vehicle or apoE was placed directly in the ventricle. Transient global cerebral ischemia induced by bilateral carotid artery occlusion for a period of 17 min utes in wild-type mice is associated with selective neu ronal damage. In this model, as we previously demon strated, there is significantly greater neuronal damage in apoE-deficient mice than wild-type mice (Horsburgh et aI., 1999b) . A nonbiased quantitation of the number of normal and ischemic neurons was performed in the cau date nucleus. In the present study, as expected, apoE deficient mice infused with vehicle had twice as much neuronal damage 3 days after the insult as wild-type mice infused with vehicle (47 ± 6% % versus 22 ± 5%). However, ischemic neuronal damage was significantly reduced in apoE-deficient mice infused for 3 days with apoE compared to vehicle-infused apoE-deficient mice (26 ± 6% versus 47 ± 6%; P = 0.0135, Fig. IA) . Isch emic neuronal damage in the apoE-deficient mice in fused with apoE was similar to that observed in wild type mice infused with vehicle (26% versus 22% respec tively). In the wild-type mice there was also a trend toward a reduction in ischemic neuronal damage in mice infused with apoE compared with vehicle (22 ± 5% ver sus 12 ± 3%; P = 0.054, Fig. 1 A) . In another brain region, the CA2 hippocampal pyramidal cell layer, there was a significant reduction in the extent of ischemic neuronal damage in apoE-deficient mice infused with A Caudate nucleus 5 ApoE-deficient Wild-type apoE compared with vehicle (5.0 ± 2.0% versus 21 ± 7%; P = 0.02, Fig. IB) . In the wild-type mice, ischemic neuronal damage was reduced in apoE-infused mice compared to vehicle-infused mice but this did not reach statistical significance (7.4 ± 2.8 versus 13.8 ± 9.3%; P = 0.25, Fig. IB) . 4-HNE immunoreactivity, a marker of lipid peroxida tion, was semiquantified in adjacent sections to those used for quantification of ischemic neuronal damage to determine whether there were alterations in lipid peroxi dation after apoE-infusion. 4-HNE immunoreactivity was minimal in morphologically normal tissue. How ever, in areas with histological evidence of ischemic damage, 4-HNE immunoreactivity was increased in the neuropil, glia, and cytoplasm of triangular neurons. Semiquantification of 4-HNE immunoreactivity indi cated there was increased 4-HNE cellular immunoreac tivity in apoE-deficient compared to wild-type mice after global ischemia (2.25 ± 0.18 versus 1.46 ± 0.14; P = 0.002, Fig. 2 ). However, the extent of 4-HNE immuno reactivity was significantly reduced in apoE-deficient mice infused with apoE compared to vehicle-infused apoE-deficient mice (1.54 ± 0.2 versus 2.25 ± 0.18; P = 0.022, Fig. 2 ). In the wild-type mice there was also a trend toward a reduction in 4-HNE immunoreactivity in mice infused with apoE compared with vehicle (1.17 ± 0.20 versus 1.46 ± 0.14). The extent of ischemic neuro nal damage was correlated with the extent of 4-HNE immunoreactivity in the wild-type and apoE-deficient mice infused with either vehicle or with apoE (r 2 = 0.73 and r 2 = 0.63; Fig. 3) .
B CA2 pyramidal ceUlayer
ApoE-deficient Wild-type 
DISCUSSION
This study demonstrates that intraventricular infusion of apoE markedly ameliorates neuronal damage with a concomitant reduction in lipid peroxidation after acute brain injury. The presence of lipid-associated apoE, throughout the postischemic period, was shown to reduce the extent of neuronal damage by approximately 50% in both apoE-deficient and wild-type mice following an episode of global ischemia. The reduction of ischemic neuronal damage paralleled a reduction in lipid peroxi dation in the apoE-deficient mice infused with apoE. This demonstrates that the increased sensitivity of apoE deficient mice to brain injury and resultant poor outcome is a consequence of reduced availability of apoE in the eNS at, or shortly after, the time of injury. The study also indicates the potential for apoE, or more realisti cally, an apoE mimetic to be used as a therapy for re ducing neuronal damage as a result of acute brain injury .
ApoE and lipids are unable to cross the blood-brain barrier and their concentrations in CSF are a reflection of the production within the CNS (Linton et aI., 1991) . In traventricular infusion of apoE ensured direct availability of apoE to the CNS. Experiments in cell cultures exposed to whole CSF demonstrate that apoE can be taken up into both neurons and astrocytes (Rebeck et aI., 1998) . A previous study indicated that recombinant apoE infusion without lipid could reduce thc chronic neurodegeneration and cognitive impairment observed in aged apoE deficient mice (Masliah et aI., 1997) . However, it is un clear whether the apoE, once infused, subsequently bound to circulating lipids in the CSF. Since we wanted to ensure that apoE, in a lipid bound form, was imme diately available at the time of injury we chose apoE complexed with very low-density lipoprotein. This in vivo neuroprotective effect of apoE illustrated in the present study is consistent with biological effects of apoE in vitro in which similar physiologic concentrations of apoE have been shown to enhance neurite outgrowth of dorsal root ganglion cells (Handelmann et aI., 1992) . These trophic effects of apoE in vitro required the pres ence of lipid, very low density lipoprotein, similar to the form of apoE infused in the present study. It should be noted that it is unclear whether the very low-density lipoprotein contained within the apoE infusion contrib uted to the neuroprotectant effect in vivo.
The principal mechanism by which apoE exerts its influence on outcome after brain injury is unclear as yet but several have been proposed. One possible mecha nism by which apoE ameliorates neuronal damage fol lowing global ischemia is by an antioxidant effect. 4-HNE immunoreactivity has been previously used to demonstrate increased lipid peroxidation after experi mental traumatic brain injury (Zhang et aI., 1999) and transient cerebral ischemia in rats (Urabe et aI., 1998) . In the present study, lipid peroxidation as indicated by (Esterbauer et al., 1991) immunoreactivity was markedly increased in the apoE-deficient compared to wild-type mice. However, apoE-infusion was associated with a reduction in lipid peroxidation. ApoE has also been shown to protect neurons from oxidative damage in cell culture (Miyata and Smith, 1996) . Another possible mechanism by which apoE could protect against isch emic insults is by reducing inf1ammatory responses (Laskowitz et al., 1997 a) . After brain injury apoE is markedly upregulated (Poirier et a!., 1991) and is in creased in neurons (Horsburgh et al., 1996 (Horsburgh et al., , 1999a ) pos sibly via receptor-mediated uptake (Poirier, 1994) . lntra neuronal apoE may protect via the transport of choles terol and lipids to neurons for repair and remodelling (Poirier, 1994) . ApoE-deficient mice have an increased sensitivity to brain injury and resultant poor outcome perhaps as a consequence of reduced availability of apoE and/or transported lipids. Intraneuronal apoE may also modulate neuronal function through an interaction with cytoskeletal proteins such as tau and microtubule asso ciated proteins (Fleming et al., 1996) . It is unclear as yet whether patients with APOE E4 have a poorer outcome after brain injury (Alberts et al., 1995; Jordan et al., 1997; Nicoll et al., 1995; Teasdale et al., 1997) because of reduced levels of apoE or because of apoE isoform-specific effects. For example, reduced concentrations of apoE have been shown in the brains of patients with Alzheimer's disease with an APOE E4 al lele (Bertrand et al., 1995) . The concentration of avail able apoE may be the factor of key importance in the response to acute brain injury. Alternatively, the isoform of the available apoE may be of major importance as many of the studies of putative mechanisms of action of apoE have shown isoform specific differences with the apoE E4 generally having reduced efficiency compared with E3. For therapeutic purposes, in patients with a head injury, a continuous intrathecal infusion could conceiv ably be used to directly deliver neuroprotective agents such as an apoE mimetic.
Our data substantiate a critical role for apoE in the response of the eNS to injury and demonstrate the po tential utility of apoE infusion as a therapy for the re duction of neuronal damage in individuals after acute brain injury.
